Dna reference standard and use thereof
AssigneeGuangzhou Igene Biotechnology Co., Ltd.
InventorsShuwei Yang, Liancheng Huang, Chen Liang, Yunyi Chen, Haiying Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeGuangzhou Igene Biotechnology Co., Ltd.
InventorsShuwei Yang, Liancheng Huang, Chen Liang, Yunyi Chen, Haiying Chen
Estimating the term…
The present invention discloses a reference DNA and the use thereof, wherein the reference DNA is selected from the group consisting of: (i) DNA fragment 1: characterized in that it carries a defined gene mutation and at least one another artificially altered base X2, wherein, as compared to a wild type of the gene, at least one defined base X1 in the defined gene mutation undergoes a mutation associated with the occurrence, diagnosis, and/or treatment (such as a target targeted by a medicament) of a disease (such as a tumor), wherein the mutation is a substitution mutation, a deletion mutation, and/or an insertion mutation, and the artificially altered base X2 is different from the mutant base X1 which is contained in the DNA of a sample to be detected and defined to be associated with the occurrence, diagnosis and/or treatment of a disease, (ii) DNA fragment 2: characterized in that it differs from the DNA fragment 1 only in that it does not comprise the defined base X1 mutation, or (iii) a mixture of the DNA fragment 1 and the DNA fragment 2.
A reference DNA, selected from the group consisting of:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.